Current antiviral combination therapy for chronic hepatitis C patients who failed to interferon alfa-based treatment.

about

Pegylated interferon and ribavirin in the retreatment of chronic hepatitis C in Korea

P2860

Q41819698-162A1187-F680-4C53-8C08-FEFAC3B7424A

P2860

Current antiviral combination therapy for chronic hepatitis C patients who failed to interferon alfa-based treatment.

Item

http://www.wikidata.org/entity/Q50550986

description

2010 nî lūn-bûn

@nan

2010年の論文

@ja

2010年学术文章

@wuu

2010年学术文章

@zh

2010年学术文章

@zh-cn

2010年学术文章

@zh-hans

2010年学术文章

@zh-my

2010年学术文章

@zh-sg

2010年學術文章

@yue

2010年學術文章

@zh-hant

name

Current antiviral combination ...... terferon alfa-based treatment.

@en

Current antiviral combination ...... terferon alfa-based treatment.

@nl

type

Item

label

Current antiviral combination ...... terferon alfa-based treatment.

@en

Current antiviral combination ...... terferon alfa-based treatment.

@nl

prefLabel

Current antiviral combination ...... terferon alfa-based treatment.

@en

Current antiviral combination ...... terferon alfa-based treatment.

@nl

P1476

Current antiviral combination ...... nterferon alfa-based treatment

@en

P2093

J A Moreno Monteagudo

http://www.w3.org/2001/XMLSchema#string

J Mendoza

http://www.w3.org/2001/XMLSchema#string

L García-Buey

http://www.w3.org/2001/XMLSchema#string

L González-Moreno

http://www.w3.org/2001/XMLSchema#string

M J Borque

http://www.w3.org/2001/XMLSchema#string

M Trapero-Marugán

http://www.w3.org/2001/XMLSchema#string

R Moreno-Otero

http://www.w3.org/2001/XMLSchema#string

P2860

Retreatment with interferon plus ribavirin of chronic hepatitis C non-responders to interferon monotherapy: a meta-analysis of individual patient data.

Interferon alfa with or without ribavirin for chronic hepatitis C: systematic review of randomised trials.

Interferon and ribavirin for patients with chronic hepatitis C who did not respond to previous interferon therapy: a meta-analysis of controlled and uncontrolled trials.

Interferon and ribavirin vs interferon alone in the re-treatment of chronic hepatitis C previously nonresponsive to interferon: A meta-analysis of randomized trials.

Meta-analysis: combination therapy with interferon-alpha 2a/2b and ribavirin for patients with chronic hepatitis C previously non-responsive to interferon.

Peginterferon alfa-2a (40KD) plus ribavirin in chronic hepatitis C patients who failed previous interferon therapy.

Chronic hepatitis C and no response to antiviral therapy: potential current and future therapeutic options.

Current and future concepts in hepatitis C therapy.

Rationale and design of the REPEAT study: a phase III, randomized, clinical trial of peginterferon alfa-2a (40 kDa) plus ribavirin in non-responders to peginterferon alfa-2b (12 kDa) plus ribavirin.

Efficacy of a second cycle of interferon therapy in patients with chronic hepatitis C.

P304

695-703

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1111/J.1365-2710.2010.01231.X

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

María Chaparro

P577

2010-12-22T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

21175705

http://www.w3.org/2001/XMLSchema#string

Current antiviral combination therapy for chronic hepatitis C patients who failed to interferon alfa-based treatment.

about

P2860

P2860

Current antiviral combination therapy for chronic hepatitis C patients who failed to interferon alfa-based treatment.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P50

P577

P698

P356

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P50

P577

P698